Cite
HARVARD Citation
Albarakati, N. et al. (n.d.). Targeting BRCA1‐BER deficient breast cancer by ATM or DNA‐PKcs blockade either alone or in combination with cisplatin for personalized therapy. Molecular oncology. 9 (1), pp. 204-217. [Online].